Document is current
Any future updates will be listed below
-
Authors
Hoffmann, E. http://orcid.org/0000-0002-9214-919X
Toepell, A.
Peter, A.
Böke, S.
De-Colle, C.
Steinle, M.
Niyazi, M.
Gani, C.
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (EH received funding as a clinician scientist „Forschungskolleg Therapieresistenz solider Tumoren“)
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 24 July 2024
First Online: 4 September 2024
Declarations
:
: E. Hoffmann, A. Toepell, A. Peter, S. Böke, C. De-Colle, M. Steinle, M. Niyazi, and C. Gani declare that they have no competing interests.
: <i>Patients’ consent</i>: This study was conducted in compliance with the Declaration of Helsinki. The study was approved by and registered with the ethics committee of the University of Tubingen (959/2021BO2). Broad consent to analyze clinical data and outcome was given. All patients agreed to genetic testing for assessing<i> DPYD</i> variants.
